Zimmer Biomet Agrees to $50M Investor Settlement
Medical device company Zimmer Biomet Holdings Inc. has agreed to pay $50 million to end investor claims it intentionally hid compliance problems at a critical manufacturing facility, thereby hurting its shareholders....To view the full article, register now.
Already a subscriber? Click here to view full article